Erlotinib Plus Ramucirumab for EGFR Mutant Lung Cancer
Dr. Sarah B. Goldberg talks with Dr. Farzanna Haffizulla on Erlotinib Plus Ramucirumab for EGFR Mutant Lung Cancer.
Video originally published on PracticeUpdate.com on 06/10/2019: https://www.practiceupdate.com/c/84612/48/1
Видео Erlotinib Plus Ramucirumab for EGFR Mutant Lung Cancer канала PracticeUpdate
Video originally published on PracticeUpdate.com on 06/10/2019: https://www.practiceupdate.com/c/84612/48/1
Видео Erlotinib Plus Ramucirumab for EGFR Mutant Lung Cancer канала PracticeUpdate
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The Immune Landscape of Residual TNBC After Neoadjuvant ChemotherapyHeroin/Opioid Addiction Among Cancer Patients – Recommendations for PatientsCancer Related AnemiaA Review of Immunotherapy and Targeted Therapy in GlioblastomaNew Concepts in Metastatic Prostate CancerSalvage vs Adjuvant Therapy in High-Risk Prostate CancerPractice Implications of Real World Data on First-Line Pazopanib in mRCCMetastatic Breast Cancer: Triple NegativePCI versus medical therapy for patients with symptomatic coronary artery disease?Interview on Multiple Myeloma TrialsGene Therapy for Advanced Parkinson’s DiseaseNew Data on Pancreatic Cancer from ASCO GISchizophrenia: Acute vs Chronic ManagementAdjuvant T-DM1 for Stage I HER2+ Breast CancerJAK2 and PD-L1 in 9p24 Amplified Breast CancerWilms' Tumor Antigen and Multiple MyelomaADA 2018: Observations from the DEVOTE trialImmunotherapy in the Management of Metastatic Triple Negative Breast CancerMitoxantrone and Veliparib in Prostate Cancer: Updates from ASCO 2017Use of Colony-Stimulating Factors Among Patients Receiving Intermediate-Risk Chemotherapies